DNAprint Genomics (DNAG)

[DorseyE]

Notable quote by management from recent PR:
"With the first pharmaceutical in our nascent drug pipeline, our Company is evolving into a genomics-based pharmaceutical company that develops innovative 'theranostic' products, which blend genomics-based tests with drugs as products to target segments of the patient population for enhanced efficacy and reduced side effects," stated DNAPrint genomics Chief Executive Officer Richard Gabriel. "Everything we have done as a company up until this point -- aggressively introducing new tests, forging new markets, expanding the envelope of genomics expectations in the fields of forensics, consumer genomics and pharmacogenomics -- has made today's announcement possible."

"DNAPrint genomics has taken a major step forward in establishing a drug pipeline that has the potential to provide the Company a significant opportunity for growth," stated Tony Frudakis, Ph.D., Founder and Chief Scientific Officer. "We are pleased that a prestigious organization such as Beth Israel Deaconess is embracing our innovative technology in the development of our first drug candidate."
http://biz.yahoo.com/prnews/050405/fltu002.html?.v=5

How do other credible sources view this event?....
Notable quote from Bio-itworld:
Bio-IT Briefs
By Bio-IT World Staff
Bio-IT World

In a step toward transforming itself into a genomics-based pharmaceutical company, DNAPrint Genomics Inc. today announced that it has acquired an exclusive worldwide license from Harvard Medical School's Beth Israel Deaconess Medical Center (BIDMC) to develop a new, more potent and longer-acting form of the anemia drug Erythropoietin (EPO). The royalty-bearing agreement creates an opportunity for DNAPrint Genomics to develop and market an improved "super"- EPO. EPO is currently commercialized by several pharmaceutical companies for a worldwide market that exceeds $10 billion. Website: www.dnaprint.com.
http://www.bio-itworld.com/news/040505_report8016.html

The world is just starting to find out what we already know.... the share price will follow!!!